Article info
PDFClinical and epidemiological research
Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors
- Correspondence to Xavier M Teitsma, Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht 3584 CX, The Netherlands; x.m.teitsma{at}umcutrecht.nl
Citation
Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors
Publication history
- Received January 17, 2018
- Revised March 30, 2018
- Accepted April 23, 2018
- First published May 14, 2018.
Online issue publication
April 08, 2023
Article Versions
- Previous version (2 August 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.